Alterations associated with the PEComatous renal and hepatic AML include biallelic loss of the tumor suppressor genes, TSC1 or TSC2, or, alternatively, TFE3 gene fusions [24]. The gene discussed is TSC2; the disease is acute myeloid leukemia.